Nuria María
Ardaiz Iriarte
Investigadora Colaboradora
Publicaciones (19) Publicaciones de Nuria María Ardaiz Iriarte
2024
-
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C
Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4
-
Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)
Clinical science (London, England : 1979), Vol. 138, Núm. 20, pp. 1265-1284
-
Peritoneal carcinomatosis in mouse models
Methods in Cell Biology (Academic Press Inc.), pp. 67-78
2023
-
Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure
Molecular Therapy - Nucleic Acids, Vol. 33, pp. 599-616
2021
-
Statins act as transient type i interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 7
2020
-
Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice
Frontiers in Pharmacology, Vol. 11
-
Long-Term Liver Expression of an Apolipoprotein A-I Mimetic Peptide Attenuates Interferon-Alpha-Induced Inflammation and Promotes Antiviral Activity
Frontiers in Immunology, Vol. 11
-
Scavenger Receptor Class B Type I is Required for 25-Hydroxycholecalciferol Cellular Uptake and Signaling in Myeloid Cells
Molecular Nutrition and Food Research, Vol. 64, Núm. 15
2019
-
Treatment of experimental autoimmune encephalomyelitis by sustained delivery of low-dose IFN-a
Journal of Immunology, Vol. 203, Núm. 3, pp. 696-704
2017
-
Antitumor effect of an adeno-associated virus expressing apolipoprotein A-1 fused to interferon alpha in an interferon alpha-resistant murine tumor model
Oncotarget, Vol. 8, Núm. 3, pp. 5247-5255
2016
-
Interferon alpha bioactivity critically depends on Scavenger receptor class B type I function
OncoImmunology, Vol. 5, Núm. 8
2015
-
Liver-directed gene therapy of chronic hepadnavirus infection using interferon alpha tethered to apolipoprotein A-I
Journal of Hepatology, Vol. 63, Núm. 2, pp. 329-336
-
Overexpression of apolipoprotein A-I fused to an anti-transforming growth factor beta peptide modulates the tumorigenicity and immunogenicity of mouse colon cancer cells
Cancer Immunology, Immunotherapy, Vol. 64, Núm. 6, pp. 717-725
2014
2012
-
A Semliki Forest virus vector engineered to express IFNα induces efficient elimination of established tumors
Gene Therapy, Vol. 19, Núm. 3, pp. 271-278
-
Kinetic and dynamic computational model-based characterization of new proteins in mice: Application to interferon alpha linked to apolipoprotein A-I
PLoS ONE, Vol. 7, Núm. 7
-
The fusion protein of IFN-α and apolipoprotein A-I crosses the blood-brain barrier by a saturable transport mechanism
Journal of Immunology, Vol. 188, Núm. 8, pp. 3988-3992
2011
-
Anchoring interferon alpha to apolipoprotein A-I reduces hematological toxicity while enhancing immunostimulatory properties
Hepatology, Vol. 53, Núm. 6, pp. 1864-1873
-
Successful colon cancer eradication after chemoimmunotherapy is associated with profound phenotypic change of intratumoral myeloid cells
Journal of Immunology, Vol. 186, Núm. 2, pp. 807-815